The latest study on Lung Cancer Diagnostics Market by Read Market Research provides a detailed summary and overview of the global market. The base year considered in this report is considered 2020 whereas information for 2021 is estimated and forecast from 2022 till 2027. The CAGR (Compound Annual Growth Rate) period of this report is 2021-2027. The Global Lung Cancer Diagnostics Market is valued at USD XX Million in the year 2020 and is estimated to grow at USD XX Million by the end of year 2027.The report will shed light on very important growth aspect of Lung Cancer Diagnostics and is a must have data for all the companies, investors, decision makers, top level executives and readers.
The segmental analysis of the report provides detailed analysis on Revenue, Growth, Forecast By Region, Type and Applications for the period 2016-2027.
The major vendors covered:
Roche Diagnostics
BioM rieux
Qiagen
Advpharma
AIT Austrian Institute of Technology
Courtagen Life Sciences
DiagnoCure
BioMark Diagnostics
Mayo Clinic
HalioDx SAS
Lung Cancer Diagnostics Market Analysis By Type Segment:
Immunoassays
Flow Cytometry
Rapid Tests
Molecular Assays
Tissue Arrays
Circulating Tumor Cells
Pharmacodiagnostics
Biomarkers
Other
Lung Cancer Diagnostics Market Analysis By Application Segment:
Industrial
Healthcare
Other
Lung Cancer Diagnostics Market Analysis By Regions (Countries):
The Lung Cancer Diagnostics Market has been thoroughly researched with the help of Primary and Secondary Research and has been validated by conduction interviews with industry experts across all the regions. As it is global study, we have included all the major regions.
Bottom Up approach has been used to derive and define the market size and shares of regions. Regions such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. has been taken into consideration while deriving the market size and shares of regions.
Key Details of Regions and Countries of Lung Cancer Diagnostics Report:
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Central & South America
Brazil
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa
Key data provided:
Market Size of Regions
Market Share of Regions
Compound Annual Growth Rate (CAGR)
Historic Data From 2016-2020
Forecast Data From 2021-2027
Competitive Landscape of Lung Cancer Diagnostics Market:
Lung Cancer Diagnostics market competitive landscape analysis sheds light on the current market structure by players. The report will help the readers to understand some most important questions of the global market.
Key Questions Answered in Competitive Landscape-
List of Key Players
Revenue By players
Market share of players
Product Offerings
The study objectives are:
To analyze and research the Lung Cancer Diagnostics Market status and future forecast.
To present the key Lung Cancer Diagnostics Market analysis of companies and present revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Lung Cancer Diagnostics Market Size Growth Rate by Type (2016-2027)
1.4.2 Immunoassays
1.4.3 Flow Cytometry
1.4.4 Rapid Tests
1.4.5 Molecular Assays
1.4.6 Tissue Arrays
1.4.7 Circulating Tumor Cells
1.4.8 Pharmacodiagnostics
1.4.9 Biomarkers
1.4.10 Other
1.5 Market by Application
1.5.1 Global Lung Cancer Diagnostics Market Share by Application (2016-2027)
1.5.2 Industrial
1.5.3 Healthcare
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Lung Cancer Diagnostics Market Size
2.2 Lung Cancer Diagnostics Growth Trends by Regions
2.2.1 Lung Cancer Diagnostics Market Size by Regions (2016-2027)
2.2.2 Lung Cancer Diagnostics Market Share by Regions (2016-2020)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Lung Cancer Diagnostics Market Size by Manufacturers
3.1.1 Global Lung Cancer Diagnostics Revenue by Manufacturers (2020)
3.1.2 Global Lung Cancer Diagnostics Revenue Market Share by Manufacturers (2020)
3.1.3 Global Lung Cancer Diagnostics Market Concentration Ratio (CR5 and HHI)
3.2 Lung Cancer Diagnostics Key Players Head office and Area Served
3.3 Key Players Lung Cancer Diagnostics Product/Solution/Service
3.4 Date of Enter into Lung Cancer Diagnostics Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Lung Cancer Diagnostics Market Size by Type (2016-2020)
4.2 Global Lung Cancer Diagnostics Market Size by Application (2016-2020)
5 United States
5.1 United States Lung Cancer Diagnostics Market Size (2016-2020)
5.2 Lung Cancer Diagnostics Key Players in United States
5.3 United States Lung Cancer Diagnostics Market Size by Type
5.4 United States Lung Cancer Diagnostics Market Size by Application
6 Europe
6.1 Europe Lung Cancer Diagnostics Market Size (2016-2020)
6.2 Lung Cancer Diagnostics Key Players in Europe
6.3 Europe Lung Cancer Diagnostics Market Size by Type
6.4 Europe Lung Cancer Diagnostics Market Size by Application
7 China
7.1 China Lung Cancer Diagnostics Market Size (2016-2020)
7.2 Lung Cancer Diagnostics Key Players in China
7.3 China Lung Cancer Diagnostics Market Size by Type
7.4 China Lung Cancer Diagnostics Market Size by Application
8 Japan
8.1 Japan Lung Cancer Diagnostics Market Size (2016-2020)
8.2 Lung Cancer Diagnostics Key Players in Japan
8.3 Japan Lung Cancer Diagnostics Market Size by Type
8.4 Japan Lung Cancer Diagnostics Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Lung Cancer Diagnostics Market Size (2016-2020)
9.2 Lung Cancer Diagnostics Key Players in Southeast Asia
9.3 Southeast Asia Lung Cancer Diagnostics Market Size by Type
9.4 Southeast Asia Lung Cancer Diagnostics Market Size by Application
10 India
10.1 India Lung Cancer Diagnostics Market Size (2016-2020)
10.2 Lung Cancer Diagnostics Key Players in India
10.3 India Lung Cancer Diagnostics Market Size by Type
10.4 India Lung Cancer Diagnostics Market Size by Application
11 Central & South America
11.1 Central & South America Lung Cancer Diagnostics Market Size (2016-2020)
11.2 Lung Cancer Diagnostics Key Players in Central & South America
11.3 Central & South America Lung Cancer Diagnostics Market Size by Type
11.4 Central & South America Lung Cancer Diagnostics Market Size by Application
12 International Players Profiles
12.1 Roche Diagnostics
12.1.1 Roche Diagnostics Company Details
12.1.2 Company Description and Business Overview
12.1.3 Lung Cancer Diagnostics Introduction
12.1.4 Roche Diagnostics Revenue in Lung Cancer Diagnostics Business (2020)
12.1.5 Roche Diagnostics Recent Development
12.2 BioM rieux
12.2.1 BioM rieux Company Details
12.2.2 Company Description and Business Overview
12.2.3 Lung Cancer Diagnostics Introduction
12.2.4 BioM rieux Revenue in Lung Cancer Diagnostics Business (2020)
12.2.5 BioM rieux Recent Development
12.3 Qiagen
12.3.1 Qiagen Company Details
12.3.2 Company Description and Business Overview
12.3.3 Lung Cancer Diagnostics Introduction
12.3.4 Qiagen Revenue in Lung Cancer Diagnostics Business (2020)
12.3.5 Qiagen Recent Development
12.4 Advpharma
12.4.1 Advpharma Company Details
12.4.2 Company Description and Business Overview
12.4.3 Lung Cancer Diagnostics Introduction
12.4.4 Advpharma Revenue in Lung Cancer Diagnostics Business (2020)
12.4.5 Advpharma Recent Development
12.5 AIT Austrian Institute of Technology
12.5.1 AIT Austrian Institute of Technology Company Details
12.5.2 Company Description and Business Overview
12.5.3 Lung Cancer Diagnostics Introduction
12.5.4 AIT Austrian Institute of Technology Revenue in Lung Cancer Diagnostics Business (2020)
12.5.5 AIT Austrian Institute of Technology Recent Development
12.6 Courtagen Life Sciences
12.6.1 Courtagen Life Sciences Company Details
12.6.2 Company Description and Business Overview
12.6.3 Lung Cancer Diagnostics Introduction
12.6.4 Courtagen Life Sciences Revenue in Lung Cancer Diagnostics Business (2020)
12.6.5 Courtagen Life Sciences Recent Development
12.7 DiagnoCure
12.7.1 DiagnoCure Company Details
12.7.2 Company Description and Business Overview
12.7.3 Lung Cancer Diagnostics Introduction
12.7.4 DiagnoCure Revenue in Lung Cancer Diagnostics Business (2020)
12.7.5 DiagnoCure Recent Development
12.8 BioMark Diagnostics
12.8.1 BioMark Diagnostics Company Details
12.8.2 Company Description and Business Overview
12.8.3 Lung Cancer Diagnostics Introduction
12.8.4 BioMark Diagnostics Revenue in Lung Cancer Diagnostics Business (2020)
12.8.5 BioMark Diagnostics Recent Development
12.9 Mayo Clinic
12.9.1 Mayo Clinic Company Details
12.9.2 Company Description and Business Overview
12.9.3 Lung Cancer Diagnostics Introduction
12.9.4 Mayo Clinic Revenue in Lung Cancer Diagnostics Business (2020)
12.9.5 Mayo Clinic Recent Development
12.10 HalioDx SAS
12.10.1 HalioDx SAS Company Details
12.10.2 Company Description and Business Overview
12.10.3 Lung Cancer Diagnostics Introduction
12.10.4 HalioDx SAS Revenue in Lung Cancer Diagnostics Business (2020)
12.10.5 HalioDx SAS Recent Development
13 Market Forecast 2021-2027
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2021-2027)
13.10 Market Size Forecast by Application (2021-2027)
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
List of Tables and Figures
List of Tables and Figures
Table Lung Cancer Diagnostics Key Market Segments
Table Key Players Lung Cancer Diagnostics Covered
Table Global Lung Cancer Diagnostics Market Size Growth Rate by Type 2016-2027 (Million US$)
Figure Global Lung Cancer Diagnostics Market Size Market Share by Type 2016-2027
Figure Immunoassays Figures
Table Key Players of Immunoassays
Figure Flow Cytometry Figures
Table Key Players of Flow Cytometry
Figure Rapid Tests Figures
Table Key Players of Rapid Tests
Figure Molecular Assays Figures
Table Key Players of Molecular Assays
Figure Tissue Arrays Figures
Table Key Players of Tissue Arrays
Figure Circulating Tumor Cells Figures
Table Key Players of Circulating Tumor Cells
Figure Pharmacodiagnostics Figures
Table Key Players of Pharmacodiagnostics
Figure Biomarkers Figures
Table Key Players of Biomarkers
Figure Other Figures
Table Key Players of Other
Table Global Lung Cancer Diagnostics Market Size Growth by Application 2016-2027 (Million US$)
Figure Industrial Case Studies
Figure Healthcare Case Studies
Figure Other Case Studies
Figure Lung Cancer Diagnostics Report Years Considered
Table Global Lung Cancer Diagnostics Market Size 2016-2027 (Million US$)
Figure Global Lung Cancer Diagnostics Market Size and Growth Rate 2016-2027 (Million US$)
Table Global Lung Cancer Diagnostics Market Size by Regions 2016-2027 (Million US$)
Table Global Lung Cancer Diagnostics Market Size by Regions 2016-2020 (Million US$)
Table Global Lung Cancer Diagnostics Market Share by Regions 2016-2020
Figure Global Lung Cancer Diagnostics Market Share by Regions 2016-2020
Figure Global Lung Cancer Diagnostics Market Share by Regions 2020
Table Market Top Trends
Table Global Lung Cancer Diagnostics Revenue by Manufacturers (2020) (Million US$)
Table Global Lung Cancer Diagnostics Market Share by Manufacturers (2020)
Figure Global Lung Cancer Diagnostics Market Share by Manufacturers in 2020
Table Global Lung Cancer Diagnostics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Lung Cancer Diagnostics Product/Solution/Service
Table Date of Enter into Lung Cancer Diagnostics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Lung Cancer Diagnostics Market Size by Type (2016-2020) (Million US$)
Table Global Lung Cancer Diagnostics Market Size Share by Type (2016-2020)
Figure Global Lung Cancer Diagnostics Market Size Market Share by Type (2016-2020)
Table Global Lung Cancer Diagnostics Market Size by Application (2016-2020) (Million US$)
Table Global Lung Cancer Diagnostics Market Size Share by Application (2016-2020)
Figure Global Lung Cancer Diagnostics Market Size Market Share by Application (2016-2020)
Figure Global Lung Cancer Diagnostics Revenue Market Share by Application in 2020
Figure United States Lung Cancer Diagnostics Market Size 2016-2020 (Million US$)
Table United States Key Players Lung Cancer Diagnostics Revenue (2020) (Million US$)
Table United States Key Players Lung Cancer Diagnostics Market Share (2020)
Table United States Lung Cancer Diagnostics Market Size by Type (2016-2020) (Million US$)
Table United States Lung Cancer Diagnostics Market Share by Type (2016-2020)
Table United States Lung Cancer Diagnostics Market Size by Application (2016-2020) (Million US$)
Table United States Lung Cancer Diagnostics Market Share by Application (2016-2020)
Figure Europe Lung Cancer Diagnostics Market Size 2016-2020 (Million US$)
Table Europe Key Players Lung Cancer Diagnostics Revenue (2020) (Million US$)
Table Europe Key Players Lung Cancer Diagnostics Market Share (2020)
Table Europe Lung Cancer Diagnostics Market Size by Type (2016-2020) (Million US$)
Table Europe Lung Cancer Diagnostics Market Share by Type (2016-2020)
Table Europe Lung Cancer Diagnostics Market Size by Application (2016-2020) (Million US$)
Table Europe Lung Cancer Diagnostics Market Share by Application (2016-2020)
Figure China Lung Cancer Diagnostics Market Size 2016-2020 (Million US$)
Table China Key Players Lung Cancer Diagnostics Revenue (2020) (Million US$)
Table China Key Players Lung Cancer Diagnostics Market Share (2020)
Table China Lung Cancer Diagnostics Market Size by Type (2016-2020) (Million US$)
Table China Lung Cancer Diagnostics Market Share by Type (2016-2020)
Table China Lung Cancer Diagnostics Market Size by Application (2016-2020) (Million US$)
Table China Lung Cancer Diagnostics Market Share by Application (2016-2020)
Figure Japan Lung Cancer Diagnostics Market Size 2016-2020 (Million US$)
Table Japan Key Players Lung Cancer Diagnostics Revenue (2020) (Million US$)
Table Japan Key Players Lung Cancer Diagnostics Market Share (2020)
Table Japan Lung Cancer Diagnostics Market Size by Type (2016-2020) (Million US$)
Table Japan Lung Cancer Diagnostics Market Share by Type (2016-2020)
Table Japan Lung Cancer Diagnostics Market Size by Application (2016-2020) (Million US$)
Table Japan Lung Cancer Diagnostics Market Share by Application (2016-2020)
Figure Southeast Asia Lung Cancer Diagnostics Market Size 2016-2020 (Million US$)
Table Southeast Asia Key Players Lung Cancer Diagnostics Revenue (2020) (Million US$)
Table Southeast Asia Key Players Lung Cancer Diagnostics Market Share (2020)
Table Southeast Asia Lung Cancer Diagnostics Market Size by Type (2016-2020) (Million US$)
Table Southeast Asia Lung Cancer Diagnostics Market Share by Type (2016-2020)
Table Southeast Asia Lung Cancer Diagnostics Market Size by Application (2016-2020) (Million US$)
Table Southeast Asia Lung Cancer Diagnostics Market Share by Application (2016-2020)
Figure India Lung Cancer Diagnostics Market Size 2016-2020 (Million US$)
Table India Key Players Lung Cancer Diagnostics Revenue (2020) (Million US$)
Table India Key Players Lung Cancer Diagnostics Market Share (2020)
Table India Lung Cancer Diagnostics Market Size by Type (2016-2020) (Million US$)
Table India Lung Cancer Diagnostics Market Share by Type (2016-2020)
Table India Lung Cancer Diagnostics Market Size by Application (2016-2020) (Million US$)
Table India Lung Cancer Diagnostics Market Share by Application (2016-2020)
Figure Central & South America Lung Cancer Diagnostics Market Size 2016-2020 (Million US$)
Table Central & South America Key Players Lung Cancer Diagnostics Revenue (2020) (Million US$)
Table Central & South America Key Players Lung Cancer Diagnostics Market Share (2020)
Table Central & South America Lung Cancer Diagnostics Market Size by Type (2016-2020) (Million US$)
Table Central & South America Lung Cancer Diagnostics Market Share by Type (2016-2020)
Table Central & South America Lung Cancer Diagnostics Market Size by Application (2016-2020) (Million US$)
Table Central & South America Lung Cancer Diagnostics Market Share by Application (2016-2020)
Table Roche Diagnostics Company Details
Table Roche Diagnostics Revenue in Lung Cancer Diagnostics Business (2020) (Million US$)
Figure Roche Diagnostics Revenue Growth Rate in Lung Cancer Diagnostics Business (2020)
Table Roche Diagnostics Recent Development
Table BioM rieux Company Details
Table BioM rieux Revenue in Lung Cancer Diagnostics Business (2020)(Million US$)
Figure BioM rieux Revenue Growth Rate in Lung Cancer Diagnostics Business (2020)
Table BioM rieux Recent Development
Table Qiagen Company Details
Table Qiagen Revenue in Lung Cancer Diagnostics Business (2020)(Million US$)
Figure Qiagen Revenue Growth Rate in Lung Cancer Diagnostics Business (2020)
Table Qiagen Recent Development
Table Advpharma Company Details
Table Advpharma Revenue in Lung Cancer Diagnostics Business (2020)(Million US$)
Figure Advpharma Revenue Growth Rate in Lung Cancer Diagnostics Business (2020)
Table Advpharma Recent Development
Table AIT Austrian Institute of Technology Company Details
Table AIT Austrian Institute of Technology Revenue in Lung Cancer Diagnostics Business (2020)(Million US$)
Figure AIT Austrian Institute of Technology Revenue Growth Rate in Lung Cancer Diagnostics Business (2020)
Table AIT Austrian Institute of Technology Recent Development
Table Courtagen Life Sciences Company Details
Table Courtagen Life Sciences Revenue in Lung Cancer Diagnostics Business (2020)(Million US$)
Figure Courtagen Life Sciences Revenue Growth Rate in Lung Cancer Diagnostics Business (2020)
Table Courtagen Life Sciences Recent Development
Table DiagnoCure Company Details
Table DiagnoCure Revenue in Lung Cancer Diagnostics Business (2020)(Million US$)
Figure DiagnoCure Revenue Growth Rate in Lung Cancer Diagnostics Business (2020)
Table DiagnoCure Recent Development
Table BioMark Diagnostics Company Details
Table BioMark Diagnostics Revenue in Lung Cancer Diagnostics Business (2020)(Million US$)
Figure BioMark Diagnostics Revenue Growth Rate in Lung Cancer Diagnostics Business (2020)
Table BioMark Diagnostics Recent Development
Table Mayo Clinic Company Details
Table Mayo Clinic Revenue in Lung Cancer Diagnostics Business (2020)(Million US$)
Figure Mayo Clinic Revenue Growth Rate in Lung Cancer Diagnostics Business (2020)
Table Mayo Clinic Recent Development
Table HalioDx SAS Company Details
Table HalioDx SAS Revenue in Lung Cancer Diagnostics Business (2020)(Million US$)
Figure HalioDx SAS Revenue Growth Rate in Lung Cancer Diagnostics Business (2020)
Table HalioDx SAS Recent Development
Table Global Lung Cancer Diagnostics Market Size by Regions (Million US$) 2021-2027
Figure Global Lung Cancer Diagnostics Market Size Share by Regions (2021-2027)
Figure Global Lung Cancer Diagnostics Market Size Share by Regions in 2027
Figure United States Lung Cancer Diagnostics Market Size Forecast (2021-2027)(Million USD)
Figure Europe Lung Cancer Diagnostics Market Size Forecast (2021-2027)(Million USD)
Figure China Lung Cancer Diagnostics Market Size Forecast (2021-2027)(Million USD)
Figure Japan Lung Cancer Diagnostics Market Size Forecast (2021-2027)(Million USD)
Figure Southeast Asia Lung Cancer Diagnostics Market Size Forecast (2021-2027)(Million USD)
Figure India Lung Cancer Diagnostics Market Size Forecast (2021-2027)(Million USD)
Figure Central & South America Lung Cancer Diagnostics Market Size Forecast (2021-2027)(Million USD)
Table Global Lung Cancer Diagnostics Market Size by Product (2021-2027) (Million US$)
Figure Global Lung Cancer Diagnostics Market Size by Product (2021-2027)
Figure Global Lung Cancer Diagnostics Market Size by Product in 2027
Table Global Lung Cancer Diagnostics Market Size by Application (2021-2027) (Million US$)
Figure Global Lung Cancer Diagnostics Market Size by Application (2021-2027)
Figure Global Lung Cancer Diagnostics Market Size by Application in 2027
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources